Internet Archive Scholar

Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 26/07/2018, Revision: 2, Status: Authorised

2019 Case Medical Research  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (83.9 kB)
https://web.archive.org/web/20181002194218/https://www.ema.europa.eu/documents/overview/trazimera-epar-medicine-overview_en.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL. The file type is application/pdf.

Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
doi:10.31525/cmr-12154e1 fatcat:7viu54wraffjxntea5s4fnfiem
Citation

"Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 26/07/2018, Revision: 2, Status: Authorised." Case Medical Research (2019)